![\"Goldman](\"https:\/\/www.newsbeep.com\/nz\/wp-content\/uploads\/2026\/03\/1773654195_969_pexels-shkrabaanthony-5214962.jpg\")
<\/p>\nIn this article, we will discuss the Goldman Sachs Healthcare Stocks: Top 10 Stock Picks.<\/p>\n
The healthcare sector, long seen as a laggard amid the artificial intelligence boom, is beginning to turn the corner. Over the past six months, the S&P 500 Healthcare sector has rallied nearly 10%, far outpacing the broader index\u2019s 0.26% gain as of March 13, underscoring its role as a defensive play in times of geopolitical and economic uncertainty. Analysts project global healthcare spending to surge from $11.2 trillion today to $20.5 trillion by 2050, driven by rising demand for health-related products and services.<\/p>\n
Yet, according to the World Economic Forum (Jan 2026), the industry faces mounting strain from ageing populations, a looming 10 million\u2011worker shortfall by 2030, and costs rising faster than GDP. Despite more than $100 billion invested in U.S. digital health since 2010, most AI solutions remain unscalable, with over 70% of FDA approvals concentrated in imaging and limited adoption due to fragmented data, strict regulations, and systemic inefficiencies.<\/p>\n
As experts stress, \u201cUnlocking the full potential of digital solutions and AI in healthcare requires coordinated stakeholder action,\u201d highlighting clinical entrepreneurship as a powerful but underutilized driver of innovation.<\/p>\n
Goldman Strategists have already touted stocks of companies with tangible, productive assets as likely to hold steady amid emerging headwinds. According to the strategists, capital-intensive stocks that derive value from physical assets are outperforming as investors turn their attention to heavy assets.<\/p>\n
\u201cMarkets are rewarding capacity, networks, infrastructure and engineering complexity\u2014assets that are costly to replicate and less exposed to technological obsolescence,\u201d wrote Guillaume Jaisson of Goldman Sachs.<\/p>\n
Morgan Stanley strategists also echo similar sentiments, signaling that the focus has shifted from asset-light sectors like software. While healthcare stocks have underperformed in recent years ,a rotation from high-flying tech stocks trading at historical norms has once again triggered renewed interest in sectors trading at highly discounted valuations.<\/p>\n
Last year, Goldman Sachs strategist David Kostin reiterated that a slump in the broader healthcare sector had created opportunities. The underperformance has resulted in valuations near record discounts at a time when other sectors, like tech, are trading above historical norms.<\/p>\n
Given the ongoing rotation away from sectors trading at premium valuations, now may be the best time to examine Goldman Sachs\u2019 top healthcare stocks in greater detail.<\/p>\n
<\/p>\n
Our Methodology<\/p>\n
To compile the list of the Goldman Sachs Healthcare Stocks: Top Stock Picks, we scanned the Goldman Sachs investment portfolio. We settled on the investment bank\u2019s top healthcare picks. We limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds.<\/p>\n
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research shows we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter\u2019s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here<\/a>).<\/p>\n